TY - JOUR
T1 - Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
AU - Balandeh, Ebrahim
AU - Mohammadshafie, Kimia
AU - Mahmoudi, Yaser
AU - Hossein Pourhanifeh, Mohammad
AU - Rajabi, Ali
AU - Bahabadi, Zahra Razaghi
AU - Mohammadi, Amir Hossein
AU - Rahimian, Neda
AU - Hamblin, Michael R.
AU - Mirzaei, Hamed
N1 - Publisher Copyright:
© Copyright © 2021 Balandeh, Mohammadshafie, Mahmoudi, Hossein Pourhanifeh, Rajabi, Bahabadi, Mohammadi, Rahimian, Hamblin and Mirzaei.
PY - 2021/9/27
Y1 - 2021/9/27
N2 - One of the significant hallmarks of cancer is angiogenesis. It has a crucial function in tumor development and metastasis. Thus, angiogenesis has become one of the most exciting targets for drug development in cancer treatment. Here we discuss the regulatory effects on angiogenesis in glioblastoma (GBM) of non-coding RNAs (ncRNAs), including long ncRNA (lncRNA), microRNA (miRNA), and circular RNA (circRNA). These ncRNAs may function in trans or cis forms and modify gene transcription by various mechanisms, including epigenetics. NcRNAs may also serve as crucial regulators of angiogenesis-inducing molecules. These molecules include, metalloproteinases, cytokines, several growth factors (platelet-derived growth factor, vascular endothelial growth factor, fibroblast growth factor, hypoxia-inducible factor-1, and epidermal growth factor), phosphoinositide 3-kinase, mitogen-activated protein kinase, and transforming growth factor signaling pathways.
AB - One of the significant hallmarks of cancer is angiogenesis. It has a crucial function in tumor development and metastasis. Thus, angiogenesis has become one of the most exciting targets for drug development in cancer treatment. Here we discuss the regulatory effects on angiogenesis in glioblastoma (GBM) of non-coding RNAs (ncRNAs), including long ncRNA (lncRNA), microRNA (miRNA), and circular RNA (circRNA). These ncRNAs may function in trans or cis forms and modify gene transcription by various mechanisms, including epigenetics. NcRNAs may also serve as crucial regulators of angiogenesis-inducing molecules. These molecules include, metalloproteinases, cytokines, several growth factors (platelet-derived growth factor, vascular endothelial growth factor, fibroblast growth factor, hypoxia-inducible factor-1, and epidermal growth factor), phosphoinositide 3-kinase, mitogen-activated protein kinase, and transforming growth factor signaling pathways.
KW - angiogenesis
KW - exosomes
KW - glioblastoma
KW - long non-coding RNAs
KW - microRNAs
KW - non-coding RNAs
UR - http://www.scopus.com/inward/record.url?scp=85116872784&partnerID=8YFLogxK
U2 - 10.3389/fcell.2021.716462
DO - 10.3389/fcell.2021.716462
M3 - Review article
AN - SCOPUS:85116872784
SN - 2296-634X
VL - 9
JO - Frontiers in Cell and Developmental Biology
JF - Frontiers in Cell and Developmental Biology
M1 - 716462
ER -